Report overview
This report contains market size and forecasts of Blood-Brain Barrier Transport Drugs in global, including the following market information:
Global Blood-Brain Barrier Transport Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Blood-Brain Barrier Transport Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Blood-Brain Barrier Transport Drugs companies in 2021 (%)
The global Blood-Brain Barrier Transport Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Carrier-mediated Transport Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Blood-Brain Barrier Transport Drugs include Cyclenium, BioAdvance, EIP Pharma, Bioasis, Immune Pharmaceuticals, AZ Therapies, Palobiofarma, Bach Pharma and BrainsGate, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Blood-Brain Barrier Transport Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood-Brain Barrier Transport Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, by Type, 2021 (%)
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others
Global Blood-Brain Barrier Transport Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, by Application, 2021 (%)
Alzheimer's Disease
Epilepsy
Parkinson's Disease
Multiple Sclerosis
Hunter's Syndrome
Brain Cancer
Others
Global Blood-Brain Barrier Transport Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood-Brain Barrier Transport Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Blood-Brain Barrier Transport Drugs revenues share in global market, 2021 (%)
Key companies Blood-Brain Barrier Transport Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Blood-Brain Barrier Transport Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics
